LAUREN HENRY: Open Payments
NPI 1508268111 · SELLERSVILLE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,587 in 124 payments from 19 companies in 2025. Trend: 2023 $1,250 · 2024 $1,565 · 2025 $2,587
Food & beverage: $2,587
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 39 | $641 |
| Takeda Pharmaceuticals U.S.A., Inc. | 15 | $287 |
| Celltrion USA Inc. | 9 | $224 |
| Janssen Biotech, Inc. | 6 | $199 |
| Ardelyx, Inc. | 6 | $185 |
| Madrigal Pharmaceuticals | 6 | $141 |
| Aimmune Therapeutics, Inc. | 5 | $122 |
| PFIZER INC. | 6 | $120 |
| Lilly USA, LLC | 6 | $118 |
| GENZYME CORPORATION | 4 | $92 |
Products named: RINVOQ, VEGZELMA, ENTYVIO, TREMFYA, IBSRELA, DUPIXENT, REZDIFFRA, ZENPEP.
Industry payments across PA — which companies pay providers there.
